These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 9686568)

  • 1. Kinetics of expression of costimulatory molecules and their ligands in murine relapsing experimental autoimmune encephalomyelitis in vivo.
    Issazadeh S; Navikas V; Schaub M; Sayegh M; Khoury S
    J Immunol; 1998 Aug; 161(3):1104-12. PubMed ID: 9686568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue-specific up-regulation of B7-1 expression and function during the course of murine relapsing experimental autoimmune encephalomyelitis.
    Karandikar NJ; Vanderlugt CL; Eagar T; Tan L; Bluestone JA; Miller SD
    J Immunol; 1998 Jul; 161(1):192-9. PubMed ID: 9647224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFN-gamma-activated primary murine astrocytes express B7 costimulatory molecules and prime naive antigen-specific T cells.
    Nikcevich KM; Gordon KB; Tan L; Hurst SD; Kroepfl JF; Gardinier M; Barrett TA; Miller SD
    J Immunol; 1997 Jan; 158(2):614-21. PubMed ID: 8992975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization in situ of the co-stimulatory molecules B7.1, B7.2, CD40 and their ligands in normal human lymphoid tissue.
    Vyth-Dreese FA; Dellemijn TA; Majoor D; de Jong D
    Eur J Immunol; 1995 Nov; 25(11):3023-9. PubMed ID: 7489738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of CD40 and its ligand, CD40L, in intestinal lesions of Crohn's disease.
    Battaglia E; Biancone L; Resegotti A; Emanuelli G; Fronda GR; Camussi G
    Am J Gastroenterol; 1999 Nov; 94(11):3279-84. PubMed ID: 10566730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation.
    Cross AH; Girard TJ; Giacoletto KS; Evans RJ; Keeling RM; Lin RF; Trotter JL; Karr RW
    J Clin Invest; 1995 Jun; 95(6):2783-9. PubMed ID: 7539461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of B7:CD28/CTLA-4 in the induction of chronic relapsing experimental allergic encephalomyelitis.
    Perrin PJ; Scott D; Quigley L; Albert PS; Feder O; Gray GS; Abe R; June CH; Racke MK
    J Immunol; 1995 Feb; 154(3):1481-90. PubMed ID: 7529805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cells are the main cell type expressing B7-1 and B7-2 in the central nervous system during acute, relapsing and chronic experimental autoimmune encephalomyelitis.
    Cross AH; Lyons JA; San M; Keeling RM; Ku G; Racke MK
    Eur J Immunol; 1999 Oct; 29(10):3140-7. PubMed ID: 10540325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and contribution of B7-1 (CD80) and B7-2 (CD86) in the early immune response to Leishmania major infection.
    Elloso MM; Scott P
    J Immunol; 1999 Jun; 162(11):6708-15. PubMed ID: 10352289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human muscle cells express a functional costimulatory molecule distinct from B7.1 (CD80) and B7.2 (CD86) in vitro and in inflammatory lesions.
    Behrens L; Kerschensteiner M; Misgeld T; Goebels N; Wekerle H; Hohlfeld R
    J Immunol; 1998 Dec; 161(11):5943-51. PubMed ID: 9834075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CTLA-4 blockade enhances clinical disease and cytokine production during experimental allergic encephalomyelitis.
    Perrin PJ; Maldonado JH; Davis TA; June CH; Racke MK
    J Immunol; 1996 Aug; 157(4):1333-6. PubMed ID: 8759711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced expression of CD80 (B7-1), CD86 (B7-2), and CD40 and their ligands CD28 and CD154 in fulminant hepatic failure.
    Leifeld L; Trautwein C; Dumoulin FL; Manns MP; Sauerbruch T; Spengler U
    Am J Pathol; 1999 Jun; 154(6):1711-20. PubMed ID: 10362796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B7.2 expressed by T cells does not induce CD28-mediated costimulatory activity but retains CTLA4 binding: implications for induction of antitumor immunity to T cell tumors.
    Greenfield EA; Howard E; Paradis T; Nguyen K; Benazzo F; McLean P; Höllsberg P; Davis G; Hafler DA; Sharpe AH; Freeman GJ; Kuchroo VK
    J Immunol; 1997 Mar; 158(5):2025-34. PubMed ID: 9036945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of T cell costimulation by CTLA4-Ig inhibits lung inflammation in murine hypersensitivity pneumonitis.
    Israël-Assayag E; Fournier M; Cormier Y
    J Immunol; 1999 Dec; 163(12):6794-9. PubMed ID: 10586079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of CD40 ligand-CD40 and CTLA4-B7 pathways in murine acute graft-versus-host disease induced by allogeneic T cells lacking CD28.
    Saito K; Sakurai J; Ohata J; Kohsaka T; Hashimoto H; Okumura K; Abe R; Azuma M
    J Immunol; 1998 May; 160(9):4225-31. PubMed ID: 9574523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B7-1, but not CD28, is crucial for the maintenance of the CD4+ T cell responses in human leprosy.
    Schlienger K; Uyemura K; Jullien D; Sieling PA; Rea TH; Linsley PS; Modlin RL
    J Immunol; 1998 Sep; 161(5):2407-13. PubMed ID: 9725237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NK cell triggering by the human costimulatory molecules CD80 and CD86.
    Wilson JL; Charo J; Martín-Fontecha A; Dellabona P; Casorati G; Chambers BJ; Kiessling R; Bejarano MT; Ljunggren HG
    J Immunol; 1999 Oct; 163(8):4207-12. PubMed ID: 10510357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costimulatory molecules in the developing human gastrointestinal tract: a pathway for fetal allergen priming.
    Jones CA; Vance GH; Power LL; Pender SL; Macdonald TT; Warner JO
    J Allergy Clin Immunol; 2001 Aug; 108(2):235-41. PubMed ID: 11496240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of human peripheral blood dendritic cells induces the CD86 co-stimulatory molecule.
    McLellan AD; Starling GC; Williams LA; Hock BD; Hart DN
    Eur J Immunol; 1995 Jul; 25(7):2064-8. PubMed ID: 7542604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B7.2 has opposing roles during the activation versus effector stages of experimental autoimmune thyroiditis.
    Peterson KE; Sharp GC; Tang H; Braley-Mullen H
    J Immunol; 1999 Feb; 162(3):1859-67. PubMed ID: 9973452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.